SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-24-017686
Filing Date
2024-04-03
Accepted
2024-04-03 18:07:11
Documents
2
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 13097
2 EXHIBIT 24 ef20026022_ex-24.htm EX-24 15792
  Complete submission text file 0001140361-24-017686.txt   30425
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 430 EAST 29TH STREET SUITE 1040 NEW YORK NY 10016
Business Address
Schwartz Jonathan David (Reporting) CIK: 0001726398 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 24820579